+++++++++++++++++++++
+Risk Model Features+
+++++++++++++++++++++
Inspection ID:
	Unique ID for a single inspection.
City:
	The city that the drug facility is located at.
State:
	The state that the drug facility is located at.
Facility name:
	The name of the facility name.
Inspection Classification:
	The outcome of the inspection. The outcome has to be NAI, VAI, or OAI.
Age of facility:
	Age since the facility was constructed.
Main Drug Name:
	The name of the drug that the facility produces the most.
Reason for failure:
	The violation code/s for the failure of the inspection.
	Same format as the citations dataset.
Size of facility:
	The size of the facility in sq. feet.
Other drugs:
	Other drugs that the facility produces besides the main drug.
Bachelors count:
	How many employees at the facility have a bachelors degree.
Masters count:
	How many employees at the facility have a masters degree.
PHD Count:
	How many employees at the facility have a PHD.
Number of employees:
	The number of employees at the facility.
Annual revenue:
	The annual revenue of the company.
Project area:
	Which of the six systems did the inspector focus on?
	options are:
	1) Bioresearch monitoring
	2) Drug Quality Assurance
	3) Over-the-counter evalution
	4) Postmarket Survey. and Epidemiology
	5) Prescription Drug Advertising
	6) Unapproved or Misbranded drugs
Date of Inspection:
	The date that the inspection was conducted.
Generic or brand?:
	Is the main drug being manufactured Generic or Brand?
	Should be a Yes or No.
Price of Drug:
	The market value price of the main drug being manufactured.
Speciality Drug?:
	Is the main drug or other drugs manufactured at this facility a specialty drug? (Yes/No)
	A specialty drug are classified as high cost and/or high touch. Specialty drugs are 
	often biologics "Drugs derived from living cells" that are injectable or infused.
	They are used to treat complex or rare chronic conditions such as cancer, H.I.V., Hepatitis C, etc.
Over-the-Counter drug?
	Is the main drug manufactured at this facility an Over-the-Counter drug? (Yes/No).
Number of facilities:
	Number of manufacutring facilities that the company has in the U.S. and Outside the U.S.
	Including this manufacturing facility.
Warning Letter?
	Did the facility receive a warning letter previously or as the result of this inspection? (Yes/No)
Medicine focus:
	What medical treatment area does the facility focus on?
	Pain killers, allergies, cancer, HIV, arthritis, nasal congestant, cold medicine, etc.